Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome
Titel:
Atezolizumab alone or in combination did not demonstrate a favorable risk-benefit profile in myelodysplastic syndrome
Auteur:
Gerds, Aaron T. Scott, Bart L. Greenberg, Peter Lin, Tara L. Pollyea, Daniel A. Verma, Amit Dail, Monique Feng, Yuning Green, Cherie Ma, Connie Medeiros, Bruno C. Yan, Mark Yousefi, Kasra Donnellan, William